
Jan Christop L. Merene
Examiner (ID: 18719, Phone: (571)270-5032 , Office: P/3733 )
| Most Active Art Unit | 3733 |
| Art Unit(s) | 3733, 3773 |
| Total Applications | 1047 |
| Issued Applications | 660 |
| Pending Applications | 88 |
| Abandoned Applications | 313 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5337275
[patent_doc_number] => 20090053739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Ligand for G-protein coupled receptor FPRL2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/075849
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 37966
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053739.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075849
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075849 | Ligand for G-protein coupled receptor FPRL2 | Mar 12, 2008 | Issued |
Array
(
[id] => 4718637
[patent_doc_number] => 20080241159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'METHODS AND COMPOSITIONS FOR SELECTIVE MODULATION OF VASCULARIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/046795
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18800
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241159.pdf
[firstpage_image] =>[orig_patent_app_number] => 12046795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/046795 | Methods and compositions for selective modulation of vascularization | Mar 11, 2008 | Issued |
Array
(
[id] => 6317190
[patent_doc_number] => 20100112617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Evaluating RTK Target Drugs'
[patent_app_type] => utility
[patent_app_number] => 12/532396
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3202
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112617.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532396
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532396 | Evaluating RTK Target Drugs | Mar 6, 2008 | Abandoned |
Array
(
[id] => 10567386
[patent_doc_number] => 09290543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Compositions and methods for the therapy and diagnosis of inflammatory bowel disease'
[patent_app_type] => utility
[patent_app_number] => 12/036588
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 41672
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12036588
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036588 | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease | Feb 24, 2008 | Issued |
Array
(
[id] => 4719438
[patent_doc_number] => 20080241961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'DROSOPHILA G PROTEIN COUPLED RECEPTORS, NUCLEIC ACIDS, AND MEHTODS RELATED TO THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/032029
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36553
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241961.pdf
[firstpage_image] =>[orig_patent_app_number] => 12032029
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/032029 | DROSOPHILA G PROTEIN COUPLED RECEPTORS, NUCLEIC ACIDS, AND MEHTODS RELATED TO THE SAME | Feb 14, 2008 | Abandoned |
Array
(
[id] => 6465062
[patent_doc_number] => 20100190701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'GLUCAGON/GLP-1 RECEPTOR CO-AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/527140
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 34095
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190701.pdf
[firstpage_image] =>[orig_patent_app_number] => 12527140
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527140 | Glucagon/GLP-1 receptor co-agonists | Feb 12, 2008 | Issued |
Array
(
[id] => 5545295
[patent_doc_number] => 20090155172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Antibodies to MAGMAS and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/020524
[patent_app_country] => US
[patent_app_date] => 2008-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23414
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155172.pdf
[firstpage_image] =>[orig_patent_app_number] => 12020524
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/020524 | Antibodies to MAGMAS and uses thereof | Jan 25, 2008 | Abandoned |
Array
(
[id] => 4954908
[patent_doc_number] => 20080187932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Single Nucleotide Polymorphisms in Protein-Tyrosine Phosphatase Receptor-Type Delta for the Diagnosis of Susceptibility to Infection and Asthma'
[patent_app_type] => utility
[patent_app_number] => 12/018792
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4793
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187932.pdf
[firstpage_image] =>[orig_patent_app_number] => 12018792
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/018792 | Single nucleotide polymorphisms in protein-tyrosine phosphatase receptor-type delta for the diagnosis of susceptibility to asthma | Jan 22, 2008 | Issued |
Array
(
[id] => 5289980
[patent_doc_number] => 20090022710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'NUCLEAR FACTOR OF ACTIVATED T CELLS RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/016447
[patent_app_country] => US
[patent_app_date] => 2008-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13228
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022710.pdf
[firstpage_image] =>[orig_patent_app_number] => 12016447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/016447 | NUCLEAR FACTOR OF ACTIVATED T CELLS RECEPTOR | Jan 17, 2008 | Abandoned |
Array
(
[id] => 5322916
[patent_doc_number] => 20090060906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Anti-IL-13 antibody formulations and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/008129
[patent_app_country] => US
[patent_app_date] => 2008-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 19854
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060906.pdf
[firstpage_image] =>[orig_patent_app_number] => 12008129
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/008129 | Anti-IL-13 antibody formulations and uses thereof | Jan 8, 2008 | Abandoned |
Array
(
[id] => 4904036
[patent_doc_number] => 20080113449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Novel receptors'
[patent_app_type] => utility
[patent_app_number] => 11/971360
[patent_app_country] => US
[patent_app_date] => 2008-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24311
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11971360
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/971360 | Novel receptors | Jan 8, 2008 | Abandoned |
Array
(
[id] => 4791650
[patent_doc_number] => 20080292623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/959796
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31146
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292623.pdf
[firstpage_image] =>[orig_patent_app_number] => 11959796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/959796 | DAP12 nucleic acids | Dec 18, 2007 | Issued |
Array
(
[id] => 6588943
[patent_doc_number] => 20100062004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST GPCRS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF GPCR-RELATED DISEASES AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/520299
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 109113
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062004.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520299 | AMINO ACID SEQUENCES DIRECTED AGAINST GPCRS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF GPCR-RELATED DISEASES AND DISORDERS | Dec 18, 2007 | Abandoned |
Array
(
[id] => 4926975
[patent_doc_number] => 20080166338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'IL-21 AS A REGULATOR OF IMMUNOGLOBIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 11/958540
[patent_app_country] => US
[patent_app_date] => 2007-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25358
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20080166338.pdf
[firstpage_image] =>[orig_patent_app_number] => 11958540
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/958540 | IL-21 AS A REGULATOR OF IMMUNOGLOBIN PRODUCTION | Dec 17, 2007 | Abandoned |
Array
(
[id] => 6134445
[patent_doc_number] => 20110008347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'CANCER-RELATED PROTEIN KINASES'
[patent_app_type] => utility
[patent_app_number] => 12/517050
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 307
[patent_figures_cnt] => 307
[patent_no_of_words] => 48359
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12517050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/517050 | CANCER-RELATED PROTEIN KINASES | Dec 2, 2007 | Abandoned |
Array
(
[id] => 5441372
[patent_doc_number] => 20090093011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Biosensors for ligand-directed functional selectivity'
[patent_app_type] => utility
[patent_app_number] => 11/998521
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13768
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11998521
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/998521 | Biosensors for ligand-directed functional selectivity | Nov 29, 2007 | Abandoned |
Array
(
[id] => 6251932
[patent_doc_number] => 20100028342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR ANTAGONISTS FOR MODULATION OF WEIGHT AND LIPOSITY'
[patent_app_type] => utility
[patent_app_number] => 12/514809
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16236
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028342.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514809
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514809 | INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR ANTAGONISTS FOR MODULATION OF WEIGHT AND LIPOSITY | Nov 28, 2007 | Abandoned |
Array
(
[id] => 4718632
[patent_doc_number] => 20080241154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family'
[patent_app_type] => utility
[patent_app_number] => 11/946668
[patent_app_country] => US
[patent_app_date] => 2007-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46199
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241154.pdf
[firstpage_image] =>[orig_patent_app_number] => 11946668
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/946668 | Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family | Nov 27, 2007 | Abandoned |
Array
(
[id] => 6551376
[patent_doc_number] => 20100222559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO RABBIT-DERIVED lgG ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/516293
[patent_app_country] => US
[patent_app_date] => 2007-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4272
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222559.pdf
[firstpage_image] =>[orig_patent_app_number] => 12516293
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516293 | Nucleic acid molecule capable of binding to rabbit-derived IgG antibody | Nov 21, 2007 | Issued |
Array
(
[id] => 6569135
[patent_doc_number] => 20100234417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'THYROTROPIN RELEASING HORMONE RECEPTOR-OREXIN RECEPTOR HETERO-DIMERS/-OLIGOMERS'
[patent_app_type] => utility
[patent_app_number] => 12/514034
[patent_app_country] => US
[patent_app_date] => 2007-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17494
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514034 | THYROTROPIN RELEASING HORMONE RECEPTOR-OREXIN RECEPTOR HETERO-DIMERS/-OLIGOMERS | Nov 8, 2007 | Abandoned |